indirubin has been researched along with Breast Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liang, C; Liu, C; Qiang, T; Ren, X; Shi, Z; Tian, L; Xing, Y | 1 |
| Kanno, Y; Kase, A; Kizu, R; Nemoto, K; Ozawa, M; Sanada, N; Taga, C; Yamashita, N; Yoshizuka, A | 1 |
| Renaud, M; Rivest, P; Sanderson, JT | 1 |
| Digiovanni, J; Miyoshi, K; Sano, S; Takaishi, M | 1 |
| Eisele, L; Hussain, MM; Katz, BH; Spink, BC; Spink, DC | 1 |
| Buettner, R; Cheng, JQ; Eisenbrand, G; Hippe, F; Jove, R; Kim, D; Merz, KH; Muehlbeyer, S; Nam, S; Turkson, J; Vatter, S | 1 |
1 review(s) available for indirubin and Breast Cancer
| Article | Year |
|---|---|
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; Female; Humans; Pharmaceutical Preparations; Protein Kinase Inhibitors | 2022 |
5 other study(ies) available for indirubin and Breast Cancer
| Article | Year |
|---|---|
Activation of the aryl hydrocarbon receptor by 3-methylcholanthrene, but not by indirubin, suppresses mammosphere formation via downregulation of CDC20 expression in breast cancer cells.
Topics: Breast Neoplasms; Cdc20 Proteins; Cell Line, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Methylcholanthrene; Receptors, Aryl Hydrocarbon; Spheroids, Cellular; Transcriptome | 2021 |
Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
Topics: Androgen Antagonists; Antibiotics, Antineoplastic; Apoptosis; beta Catenin; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Luciferases; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Time Factors; Tumor Cells, Cultured | 2011 |
Attenuation of psoriasis-like skin lesion in a mouse model by topical treatment with indirubin and its derivative E804.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Female; Humans; Indoles; Keratinocytes; Male; Mice; Oximes; Prostatic Neoplasms; Psoriasis; Sequence Analysis, DNA; Signal Transduction; Skin; Up-Regulation | 2012 |
Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin.
Topics: Antibiotics, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Enzyme Induction; Estrogens; Female; Humans; Indoles; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; RNA, Messenger; Tumor Cells, Cultured | 2003 |
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA-Binding Proteins; Female; Growth Inhibitors; Humans; Indoles; Inhibitor of Apoptosis Proteins; Kinetics; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Survivin; Trans-Activators | 2005 |